Dec 11: 1 Strong Theme — Biosimilars
1 strong theme — 1 recurred. Top: Biosimilars +6.6%.
Average change by strong theme
Theme leaders · recent trend
| Theme | Leader | Change | Trend |
|---|---|---|---|
| Biosimilars | Celltrion Healthcare | +8.73% | - |
Biosimilars returned to the strong-theme list on Dec 11, 2017 after a gap of 766 days. All 5 stocks in the theme rose, for an average change of 6.6%.
Celltrion Healthcare led the group with a gain of 8.73%, closing at 71927 on volume of 2263435 shares. Hanmi Pharm rose 6.73% and Samsung Biologics added 6.38%.
Daewoong Pharma gained 6.25%, and Celltrion Pharm rose 4.91% on the group’s heaviest volume of 2725221 shares.
Today’s Strong Themes at a Glance
| # | Theme | Status | Avg. change | Up/Total | Leader |
|---|---|---|---|---|---|
| 1 | Biosimilars | recurred after 766 days | +6.6% | 5/5 | Celltrion Healthcare |
Theme by Theme
1. Biosimilars (recurred after 766 days)
- Episode: started 2017-12-11, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
Celltrion Healthcare 091990 | +8.7% | 71,927 | ★ |
Hanmi Pharm 128940 | +6.7% | 500,822 | |
Samsung Biologics 207940 | +6.4% | 521,444 | |
Daewoong Pharma 069620 | +6.2% | 136,000 | |
Celltrion Pharm 068760 | +4.9% | 46,865 |
Related news
- [fnRASSI]셀트리온헬스케어(091990) 현재 8.34% ↑ — 파이낸셜뉴스 (Korean)
- 셀트리온헬스케어·신라젠, 빛바란 MSCI 편입효과…외국인도 물렸다 — 이데일리 (Korean)
- 12월 11일 기관 순매수 상위 종목(코스닥) 셀트리온·셀트리온헬스케어·웹젠 등 — 헤럴드경제 (Korean)
Closing Thoughts
A same-day Korean news report listed Celltrion Healthcare among the top KOSDAQ institutional net buys. Another said the MSCI inclusion effect had faded for foreign buyers.
The current episode has lasted 1 day, so the next sessions will show whether the streak continues. Another point to track is whether all 5 stocks keep moving together.